Location History:
- Miami, FL (US) (2004)
- Sellersburg, IN (US) (2018)
- New Albany, IN (US) (2015 - 2020)
Company Filing History:
4 out of 382 
1 out of 832,966 Years Active: 2004-2020
Title: Michael E Brier: Innovator in Personalized Medicine
Introduction
Michael E Brier is a notable inventor based in New Albany, IN (US). He has made significant contributions to the field of personalized medicine, holding a total of 5 patents. His work focuses on developing systems and methods that enhance the efficacy of pharmacologic agents tailored to individual patient needs.
Latest Patents
One of his latest patents is titled "System and method for personalized dosing of pharmacologic agents." This invention involves executing a plurality of dosing regimen program modules to determine various dose sets based on a target response value provided by an input device. Additionally, it employs a dosing selection algorithm to recommend a dose set that is computed as a combination of the plurality of dose sets, weighted by degrees of matching using fuzzy sets and the patient's response profile. Another significant patent is "Methods and kits for predicting a response to an erythropoietic agent." This method includes analyzing a biological sample to determine the amount of specific peptides, which can predict a subject's response to erythropoietic agents based on measurable differences compared to control levels.
Career Highlights
Michael has worked with the University of Louisville Research Foundation, Inc., where he has contributed to various research initiatives. His innovative approaches have paved the way for advancements in personalized medicine, making treatments more effective for patients.
Collaborations
Throughout his career, Michael has collaborated with notable individuals such as Adam E Gaweda and George R Aronoff. These partnerships have further enriched his research and development efforts in the medical field.
Conclusion
Michael E Brier's contributions to personalized medicine through his innovative patents and collaborations highlight his role as a significant inventor in the healthcare industry. His work continues to influence the way pharmacologic agents are administered, ultimately improving patient outcomes.